Searched for: subject%3A%22monoclonal%255C%2Bantibodies%22
(1 - 2 of 2)
Neves Sao Pedro, M. (author), Klijn, M.E. (author), Eppink, Michel H.M. (author), Ottens, M. (author)
The transition to continuous biomanufacturing is considered the next step to reduce costs and improve process robustness in the biopharmaceutical industry, while also improving productivity and product quality. The platform production process for monoclonal antibodies (mAbs) is eligible for continuous processing to lower manufacturing costs...
review 2021
Tsintavi, E. (author)
The efficacy and safety of biopharmaceutical products, combined with their ability to address previously untreated conditions, has made the biopharmaceutical field the fastest growing part of the industry. Due to their unique properties, monoclonal antibodies (mAbs) and therapeutic enzymes represent the most used macromolecules for...
master thesis 2015